Extensively drug-resistant gonorrhoea: risk of further dissemination within and across Europe
ECDC comment on the study 'Detection in the United Kingdom of the Neisseria gonorrhoeae FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, October to December 2018' by Eyre et al. in the Eurosurveillance edition of 7 March 2019.
Rapid risk assessment: Outbreak of VIM-producing carbapenem-resistant Pseudomonas aeruginosa linked to medical tourism to Mexico
This outbreak of Verona integron-encoded metallo-beta-lactamase-producing carbapenem-resistant Pseudomonas aeruginosa (VIM-CRPA) surgical site infections, related to invasive procedures performed in healthcare facilities in Tijuana, Baja California, Mexico, highlights the risks associated with medical tourism for patients and healthcare systems in the countries of origin.
Gonorrhoea: drug resistance compromises recommended treatment in Europe
Gonorrhoea is the second most commonly notified sexually transmitted infection across the EU/EEA countries with almost 500 000 reported cases between 2007 and 2016. The infection is treatable but Neisseria gonorrhoeae keep showing high levels of azithromycin resistance according to latest results of the European Gonococcal Antimicrobial Surveillance Programme.
Zoonoses: antimicrobial resistance shows no signs of slowing down
Data released today by the European Centre for Disease Prevention and Control (ECDC) and European Food Safety Authority (EFSA) reveal that antimicrobials used to treat diseases that can be transmitted between animals and humans, such as campylobacteriosis and salmonellosis, are becoming less effective.
The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2017
The data on antimicrobial resistance in zoonotic and indicator bacteria in 2017, submitted by 28 EU Member States (MSs), were jointly analysed by EFSA and ECDC. Resistance in zoonotic Salmonella and Campylobacter from humans, animals and food, and resistance in indicator Escherichia coli as well as meticillin-resistant Staphylococcus aureus in animals and food were addressed, and temporal trends assessed.
Survey of healthcare workers’ knowledge and attitudes about antibiotics and antibiotic resistance
On 28 January, Public Health England (PHE) launched a new multilingual survey, funded by the European Centre for Disease Prevention and Control (ECDC), which aims to gain an understanding of European healthcare workers’ knowledge and attitudes about antibiotics and antibiotic resistance.
ECDC country visit to Norway to discuss antimicrobial resistance issues
An ECDC country visit team conducted an assessment mission during the period 12–16 March 2018 to discuss antimicrobial resistance (AMR) issues in Norway. The overall objective of the mission was to provide an observation-based assessment of the situation in Norway regarding prevention and control of AMR through prudent use of antibiotics and infection control.
Expert consensus protocol on carbapenem resistance detection and characterisation for the survey of carbapenem- and/or colistin-resistant Enterobacteriaceae
This expert consensus protocol for carbapenem resistance detection and characterisation was jointly developed by the EURGenCCRE consortium, the scientific advisory board for EURGen-Net and ECDC to agree upon the protocol for phenotypic and genotypic carbapenem resistance detection and confirmation to be used for the CCRE survey.
Expert consensus protocol on colistin resistance detection and characterisation for the survey of carbapenem- and/or colistin-resistant Enterobacteriaceae
This expert consensus protocol for colistin resistance detection and characterisation was jointly developed by the EURGen CCRE consortium, the scientific advisory board for EURGen-Net and ECDC to agree upon the best available strategy for phenotypic and genotypic colistin-resistance detection and confirmation to be used for the CCRE survey.
Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals - ECDC PPS validation protocol version 3.1.2.
This protocol version is an accompanying document to the ECDC protocol for the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals version 5.3.